Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20979472

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2010 Oct 28
First author
Butrynski JE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2010 Oct 28;363(18):1760-2. doi: 10.1056/NEJMe1010404.
    note
    Source null
    related pmid
    20979477
    relationship
    Comment in
  2. citation
    Nat Rev Cancer. 2010 Dec;10(12):817. doi: 10.1038/nrc2976.
    note
    Source null
    related pmid
    21155181
    relationship
    Comment in
  3. citation
    N Engl J Med. 2011 Feb 24;364(8):777; author reply 778-9. doi: 10.1056/NEJMc1013325.
    note
    Source null
    related pmid
    21345112
    relationship
    Comment in

Authors and identifiers

  1. name
    Butrynski JE
    type
    Author
  2. name
    D'Adamo DR
    type
    Author
  3. name
    Hornick JL
    type
    Author
  4. name
    Dal Cin P
    type
    Author
  5. name
    Antonescu CR
    type
    Author
  6. name
    Jhanwar SC
    type
    Author
  7. name
    Ladanyi M
    type
    Author
  8. name
    Capelletti M
    type
    Author
  9. name
    Rodig SJ
    type
    Author
  10. name
    Ramaiya N
    type
    Author
  11. name
    Kwak EL
    type
    Author
  12. name
    Clark JW
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Butrynski JE
    type
    Author
  2. name
    D'Adamo DR
    type
    Author
  3. name
    Hornick JL
    type
    Author
  4. name
    Dal Cin P
    type
    Author
  5. name
    Antonescu CR
    type
    Author
  6. name
    Jhanwar SC
    type
    Author
  7. name
    Ladanyi M
    type
    Author
  8. name
    Capelletti M
    type
    Author
  9. name
    Rodig SJ
    type
    Author
  10. name
    Ramaiya N
    type
    Author
  11. name
    Kwak EL
    type
    Author
  12. name
    Clark JW
    type
    Author
bibliography ids
  1. nci-bib-094bb7ed7b993a613572dcf4
book metadata
content sha256
5df6e3e538cc6f948cf6eb58079e157fcd58d08b3e5db1d0f8c65b6edee58035
document type
citation
dois
  1. 10.1056/NEJMoa1007056
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:20979472
immutable id
pubmed:20979472@5df6e3e538cc6f948cf6eb58079e157fcd58d08b3e5db1d0f8c65b6edee58035
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
18
name
The New England journal of medicine
nlm unique id
0255562
pages
1727-33
volume
363
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2010 Oct 28;363(18):1760-2. doi: 10.1056/NEJMe1010404.
    note
    Source null
    related pmid
    20979477
    relationship
    Comment in
  2. citation
    Nat Rev Cancer. 2010 Dec;10(12):817. doi: 10.1038/nrc2976.
    note
    Source null
    related pmid
    21155181
    relationship
    Comment in
  3. citation
    N Engl J Med. 2011 Feb 24;364(8):777; author reply 778-9. doi: 10.1056/NEJMc1013325.
    note
    Source null
    related pmid
    21345112
    relationship
    Comment in
outcomes validated
false
pmid
20979472
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
916ce8ee3715b28ada76f7ed40217e8d021bb4d1958876163a44917e849590da
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Oct 28
precision
day
year
2010
publication types
  1. Case Reports
  2. Clinical Trial, Phase I
  3. Journal Article
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20979472/
title
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Preserved source evidence · Not medical advice